On September 1, 2021 Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) technology, reported participation in the following investor conferences during the month of September (Press release, Exicure, SEP 1, 2021, View Source [SID1234587116]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual Biopharma Conference 2021
One-on-one meetings
September 8-10, 2021

H.C. Wainwright 23rd Annual Global Investment Conference
Presentation Time: 7:00 AM ET
Virtual webcast here
Monday, September 13, 2021

Baird Global Healthcare Conference
Presentation Time: 9:40 AM ET
Tuesday, September 14, 2021

Replays of the H.C. Wainwright webcast will be available on Exicure’s website for 30 days following the event.